Triple-binding-oxime-III
General
Chemical_Nomenclature : (2~{E})-2-hydroxyimino-~{N}-[(1~{S})-3-[4-[(2-methylimidazol-1-yl)methyl]-1,2,3-triazol-1-yl]-1-phenyl-propyl]ethanamide
Canonical SMILES : C1=CC=CC=C1C(NC(=O)C=NO)CC[N]2N=NC(=C2)C[N]3C(=NC=C3)C
InChI : InChI=1S\/C18H21N7O2\/c1-14-19-8-10-24(14)12-16-13-25(23-22-16)9-7-17(21-18(26)11-20-27)15-5-3-2-4-6-15\/h2-6,8,10-11,13,17,27H,7,9,12H2,1H3,(H,21,26)
InChIKey : ZMAXDRHDDCRKQC-UHFFFAOYSA-N, ZMAXDRHDDCRKQC-PBGVMVHZSA-N
Other name(s) : methylimidazole derivative of 2-hydroxyimino-N-(azidophenylpropyl)acetamide || MXK || 2-(N-hydroxyimino)-N-[(1S)-3-{4-[(2-methyl-1H-imidazol-1-yl)methyl]-1H-1,2,3-triazol-1-yl}-1- phenylpropyl]acetamide
MW : 367.41
Formula : C18H21N7O2
CAS_number :
PubChem :
UniChem : ZMAXDRHDDCRKQC-UHFFFAOYSA-N, ZMAXDRHDDCRKQC-PBGVMVHZSA-N
Target
Structure : 6T9S
Families : No family
References (1)
| Title : Enantioseparation, in vitro testing, and structural characterization of triple-binding reactivators of organophosphate-inhibited cholinesterases - Marakovic_2020_Biochem.J_477_2771 |
| Author(s) : Marakovic N , Knezevic A , Roncevic I , Brazzolotto X , Kovarik Z , Sinko G |
| Ref : Biochemical Journal , 477 :2771 , 2020 |
| Abstract : |
| PubMedSearch : Marakovic_2020_Biochem.J_477_2771 |
| PubMedID: 32639532 |
| Gene_locus related to this paper: human-BCHE |